Suvoda's Latest Platform Enhancements Revolutionize Clinical Trial Operations and Patient Engagement
On September 30, 2026, Suvoda, a global leader in clinical trial technology, unveiled the latest version of its platform, marking a significant evolution in its offerings. This new iteration unifies the outstanding products of Suvoda and Greenphire into a singular, comprehensive platform designed to streamline clinical trial operations. With cutting-edge AI capabilities and user-friendly enhancements, this platform not only reduces manual workload but also empowers patients, clinical sites, and sponsors with more flexible technology solutions.
The core innovation of the new Suvoda platform is its ability to connect various technologies and services at critical moments during clinical trials. Traditionally, clinical trial teams faced the daunting task of piecing together disparate technologies that were not originally designed to integrate seamlessly. They often needed to juggle multiple vendors, login credentials, and support teams to manage aspects of the trial such as randomization, drug supply, e-Consent, payments, travel, and patient consent. Suvoda's latest platform solves these challenges by creating a unified, integrated experience where every function is linked, simplifying the process dramatically.
1. AI Integration Across the Platform: The integration of AI is foundational to the platform's new capabilities. Starting with Real-Time Study Management (RTSM) and electronic Clinical Outcome Assessments (eCOA), AI features will expand to financial services, elevating patient payment processes. Notably, the capacity of Suvoda's RTSM can cut project launch to User Acceptance Testing (UAT) timelines by as much as 80%. Moreover, Suvoda has introduced Sofia, a conversational AI assistant that aids sponsors and sites in accessing crucial information in multiple languages while maintaining audit trails for actions taken.
2. Unified Connectivity for Eight Integrated Products: Marking a major leap forward, the new Product Launchpad facilitates trial teams in navigating diverse functionalities—RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Site Payments, and Budgeting—all without switching systems. Data entered by participants in the RTSM is automatically shared across products, eliminating the need for repetitive data entry, improving efficiency significantly.
3. Accelerated and Secure Decision-Making for Sponsors and CROs: Enhanced reporting capabilities and self-service options empower sponsors and Contract Research Organizations (CROs) with more control over their data. A new dedicated portal for financial and travel reporting delivers real-time access to study data. Notably, the Budgeting/Benchmarking feature now allows negotiations to take place directly on the platform, integrating payment data for immediate market value adjustments.
4. Optimized Patient Experience: Suvoda’s award-winning app offers patients a streamlined interface for managing appointments, booking travel, completing surveys, and receiving micropayments when tasks are accomplished. Clinical sites can now conduct remote consultations and display their availability to facilitate appointment setting. Patients worldwide can choose their preferred reimbursement method, including popular digital wallets like Alipay in China, thus minimizing inquiries about payments and travel statuses for clinical sites.
CEO Jagath Wanninayake emphasized that this version exemplifies what can be achieved through a unified, AI-driven product suite. It allows clinical sites to spend less time on technology alignment, patients to enjoy a simplified experience during clinical trials, and sponsors to receive timely answers to critical questions. The successful merger with Greenphire, a leader in financial management tools for clinical trials, only enhances Suvoda's ability to provide connected solutions designed to keep life-changing studies progressing even in the most urgent and mission-critical moments. For further information, visit suvoda.com and follow Suvoda on LinkedIn.
The core innovation of the new Suvoda platform is its ability to connect various technologies and services at critical moments during clinical trials. Traditionally, clinical trial teams faced the daunting task of piecing together disparate technologies that were not originally designed to integrate seamlessly. They often needed to juggle multiple vendors, login credentials, and support teams to manage aspects of the trial such as randomization, drug supply, e-Consent, payments, travel, and patient consent. Suvoda's latest platform solves these challenges by creating a unified, integrated experience where every function is linked, simplifying the process dramatically.
Key Enhancements
1. AI Integration Across the Platform: The integration of AI is foundational to the platform's new capabilities. Starting with Real-Time Study Management (RTSM) and electronic Clinical Outcome Assessments (eCOA), AI features will expand to financial services, elevating patient payment processes. Notably, the capacity of Suvoda's RTSM can cut project launch to User Acceptance Testing (UAT) timelines by as much as 80%. Moreover, Suvoda has introduced Sofia, a conversational AI assistant that aids sponsors and sites in accessing crucial information in multiple languages while maintaining audit trails for actions taken.
2. Unified Connectivity for Eight Integrated Products: Marking a major leap forward, the new Product Launchpad facilitates trial teams in navigating diverse functionalities—RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Site Payments, and Budgeting—all without switching systems. Data entered by participants in the RTSM is automatically shared across products, eliminating the need for repetitive data entry, improving efficiency significantly.
3. Accelerated and Secure Decision-Making for Sponsors and CROs: Enhanced reporting capabilities and self-service options empower sponsors and Contract Research Organizations (CROs) with more control over their data. A new dedicated portal for financial and travel reporting delivers real-time access to study data. Notably, the Budgeting/Benchmarking feature now allows negotiations to take place directly on the platform, integrating payment data for immediate market value adjustments.
4. Optimized Patient Experience: Suvoda’s award-winning app offers patients a streamlined interface for managing appointments, booking travel, completing surveys, and receiving micropayments when tasks are accomplished. Clinical sites can now conduct remote consultations and display their availability to facilitate appointment setting. Patients worldwide can choose their preferred reimbursement method, including popular digital wallets like Alipay in China, thus minimizing inquiries about payments and travel statuses for clinical sites.
CEO Jagath Wanninayake emphasized that this version exemplifies what can be achieved through a unified, AI-driven product suite. It allows clinical sites to spend less time on technology alignment, patients to enjoy a simplified experience during clinical trials, and sponsors to receive timely answers to critical questions. The successful merger with Greenphire, a leader in financial management tools for clinical trials, only enhances Suvoda's ability to provide connected solutions designed to keep life-changing studies progressing even in the most urgent and mission-critical moments. For further information, visit suvoda.com and follow Suvoda on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.